Heart failure (HF) is a disease with high morbidity and mortality in Brazil and in the world, and HF with preserved ejection fraction (HFpEF) accounts for more than half of cases. Effective pharmacological treatment options for HFpEF are scarce, with poor outcomes and an annual mortality of 10 to 30%. Mortality from noncardiovascular causes is high, which is to be expected given the high number of comorbidities (). The syndromic diagnosis is composed of several etiologies and diseases, each one […]